160 related articles for article (PubMed ID: 29719626)
1. Identification of specific and common diagnostic antibody markers for gastrointestinal cancers by SEREX screening using testis cDNA phage library.
Kobayashi S; Hiwasa T; Arasawa T; Kagaya A; Ishii S; Shimada H; Ito M; Suzuki M; Kano M; Rahmutulla B; Kitamura K; Sawabe Y; Shin H; Takiguchi M; Nomura F; Matsubara H; Matsushita K
Oncotarget; 2018 Apr; 9(26):18559-18569. PubMed ID: 29719626
[TBL] [Abstract][Full Text] [Related]
2. Anti-FIRΔexon2, a splicing variant form of PUF60, autoantibody is detected in the sera of esophageal squamous cell carcinoma.
Kobayashi S; Hiwasa T; Ishige T; Rahmutulla B; Kano M; Hoshino T; Minamoto T; Shimada H; Nomura F; Matsubara H; Matsushita K
Cancer Sci; 2019 Jun; 110(6):2004-2013. PubMed ID: 30980774
[TBL] [Abstract][Full Text] [Related]
3. Serum anti-LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases.
Sumazaki M; Shimada H; Ito M; Shiratori F; Kobayashi E; Yoshida Y; Adachi A; Matsutani T; Iwadate Y; Mine S; Machida T; Kamitsukasa I; Mori M; Sugimoto K; Uzawa A; Kuwabara S; Kobayashi Y; Ohno M; Nishi E; Maezawa Y; Takemoto M; Yokote K; Takizawa H; Kashiwado K; Shin H; Kishimoto T; Matsushita K; Kobayashi S; Nakamura R; Shinmen N; Kuroda H; Zhang XM; Wang H; Goto KI; Hiwasa T
Cancer Sci; 2020 Dec; 111(12):4453-4464. PubMed ID: 32939876
[TBL] [Abstract][Full Text] [Related]
4. Identification of stroke-associated-antigens via screening of recombinant proteins from the human expression cDNA library (SEREX).
Machida T; Kubota M; Kobayashi E; Iwadate Y; Saeki N; Yamaura A; Nomura F; Takiguchi M; Hiwasa T
J Transl Med; 2015 Feb; 13():71. PubMed ID: 25890248
[TBL] [Abstract][Full Text] [Related]
5. Serological identification of tumor antigens of esophageal squamous cell carcinoma.
Shimada H; Nakashima K; Ochiai T; Nabeya Y; Takiguchi M; Nomura F; Hiwasa T
Int J Oncol; 2005 Jan; 26(1):77-86. PubMed ID: 15586227
[TBL] [Abstract][Full Text] [Related]
6. Serum Anti-BRAT1 is a Common Molecular Biomarker for Gastrointestinal Cancers and Atherosclerosis.
Hu L; Liu J; Shimada H; Ito M; Sugimoto K; Hiwasa T; Zhou Q; Li J; Shen S; Wang H
Front Oncol; 2022; 12():870086. PubMed ID: 35656505
[TBL] [Abstract][Full Text] [Related]
7. Identification of serum anti-striatin 4 antibodies as a common marker for esophageal cancer and other solid cancers.
Ito M; Hiwasa T; Oshima Y; Yajima S; Suzuki T; Nanami T; Sumazaki M; Shiratori F; Funahashi K; Takizawa H; Kashiwado K; Tochigi N; Shimada H
Mol Clin Oncol; 2021 Nov; 15(5):237. PubMed ID: 34650804
[TBL] [Abstract][Full Text] [Related]
8. Association of serum levels of antibodies against MMP1, CBX1, and CBX5 with transient ischemic attack and cerebral infarction.
Wang H; Zhang XM; Tomiyoshi G; Nakamura R; Shinmen N; Kuroda H; Kimura R; Mine S; Kamitsukasa I; Wada T; Aotsuka A; Yoshida Y; Kobayashi E; Matsutani T; Iwadate Y; Sugimoto K; Mori M; Uzawa A; Muto M; Kuwabara S; Takemoto M; Kobayashi K; Kawamura H; Ishibashi R; Yokote K; Ohno M; Chen PM; Nishi E; Ono K; Kimura T; Machida T; Takizawa H; Kashiwado K; Shimada H; Ito M; Goto KI; Iwase K; Ashino H; Taira A; Arita E; Takiguchi M; Hiwasa T
Oncotarget; 2018 Jan; 9(5):5600-5613. PubMed ID: 29464021
[TBL] [Abstract][Full Text] [Related]
9. Identification of antibody against wingless‑type MMTV integration site family member 7B as a biliary cancer tumor marker.
Takahashi M; Tsuchikawa T; Hiwasa T; Nakamura T; Hontani K; Kushibiki T; Inoko K; Takano H; Hatanaka Y; Matsushita K; Matsubara H; Hoshino T; Ohtsuka M; Shimada H; Tanaka K; Nakanishi Y; Asano T; Noji T; Okamura K; Shichinohe T; Hirano S
Oncol Rep; 2023 Feb; 49(2):. PubMed ID: 36562381
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel SEREX antigen family, ECSA, in esophageal squamous cell carcinoma.
Kagaya A; Shimada H; Shiratori T; Kuboshima M; Nakashima-Fujita K; Yasuraoka M; Nishimori T; Kurei S; Hachiya T; Murakami A; Tamura Y; Nomura F; Ochiai T; Matsubara H; Takiguchi M; Hiwasa T
Proteome Sci; 2011 Jun; 9(1):31. PubMed ID: 21696638
[TBL] [Abstract][Full Text] [Related]
11. Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal Cancer.
Ito M; Hiwasa T; Oshima Y; Yajima S; Suzuki T; Nanami T; Sumazaki M; Shiratori F; Funahashi K; Li SY; Iwadate Y; Yamagata H; Jambaljav B; Takemoto M; Yokote K; Takizawa H; Shimada H
Front Oncol; 2021; 11():708039. PubMed ID: 34504788
[TBL] [Abstract][Full Text] [Related]
12. [Human esophageal carcinoma antigens screened by serologic analysis of recombinant cDNA expression libraries (SEREX)].
Yu L; Hu H; Ran YL; Peng LP; Li JW; Yang ZH
Ai Zheng; 2007 Jan; 26(1):100-5. PubMed ID: 17222377
[TBL] [Abstract][Full Text] [Related]
13. Identification of HCC-22-5 tumor-associated antigen and antibody response in patients.
Zhou SF; Xie XX; Bin YH; Lan L; Chen F; Luo GR
Clin Chim Acta; 2006 Apr; 366(1-2):274-80. PubMed ID: 16356486
[TBL] [Abstract][Full Text] [Related]
14. Anti-FIRs (PUF60) auto-antibodies are detected in the sera of early-stage colon cancer patients.
Kobayashi S; Hoshino T; Hiwasa T; Satoh M; Rahmutulla B; Tsuchida S; Komukai Y; Tanaka T; Matsubara H; Shimada H; Nomura F; Matsushita K
Oncotarget; 2016 Dec; 7(50):82493-82503. PubMed ID: 27756887
[TBL] [Abstract][Full Text] [Related]
15. Proteomics-based identification of autoantibody against heat shock protein 70 as a diagnostic marker in esophageal squamous cell carcinoma.
Fujita Y; Nakanishi T; Miyamoto Y; Hiramatsu M; Mabuchi H; Miyamoto A; Shimizu A; Takubo T; Tanigawa N
Cancer Lett; 2008 May; 263(2):280-90. PubMed ID: 18334280
[TBL] [Abstract][Full Text] [Related]
16. Circulating levels of autoantibodies against L1-cell adhesion molecule as a potential diagnostic biomarker in esophageal squamous cell carcinoma.
Xu YW; Peng YH; Ran LQ; Zhai TT; Guo HP; Qiu SQ; Chen HL; Wu ZY; Li EM; Xie JJ
Clin Transl Oncol; 2017 Jul; 19(7):898-906. PubMed ID: 28181176
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel serum autoantibodies against EID3 in non-functional pancreatic neuroendocrine tumors.
Hontani K; Tsuchikawa T; Hiwasa T; Nakamura T; Ueno T; Kushibiki T; Takahashi M; Inoko K; Takano H; Takeuchi S; Dosaka-Akita H; Kuwatani M; Sakamoto N; Hatanaka Y; Mitsuhashi T; Shimada H; Shichinohe T; Hirano S
Oncotarget; 2017 Dec; 8(63):106206-106221. PubMed ID: 29290942
[TBL] [Abstract][Full Text] [Related]
18. Elevation of Autoantibody in Patients with Ischemic Stroke.
Yoshida Y; Hiwasa T; Machida T; Kobayashi E; Mine S; Matsushima J; Takiguchi M; Iwadate Y
Neurol Med Chir (Tokyo); 2018 Jul; 58(7):303-310. PubMed ID: 29848906
[TBL] [Abstract][Full Text] [Related]
19. Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis.
Li SY; Yoshida Y; Kobayashi E; Kubota M; Matsutani T; Mine S; Machida T; Maezawa Y; Takemoto M; Yokote K; Kobayashi Y; Takizawa H; Sata M; Yamagishi K; Iso H; Sawada N; Tsugane S; Kobayashi S; Matsushita K; Nomura F; Matsubara H; Sumazaki M; Ito M; Yajima S; Shimada H; Iwase K; Ashino H; Wang H; Goto K; Tomiyoshi G; Shinmen N; Nakamura R; Kuroda H; Iwadate Y; Hiwasa T
Sci Rep; 2021 Jun; 11(1):13450. PubMed ID: 34188129
[TBL] [Abstract][Full Text] [Related]
20. Association between serum anti‑ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension.
Li SY; Yoshida Y; Kobayashi E; Adachi A; Hirono S; Matsutani T; Mine S; Machida T; Ohno M; Nishi E; Maezawa Y; Takemoto M; Yokote K; Kitamura K; Sumazaki M; Ito M; Shimada H; Takizawa H; Kashiwado K; Tomiyoshi G; Shinmen N; Nakamura R; Kuroda H; Zhang XM; Wang H; Goto K; Iwadate Y; Hiwasa T
Int J Mol Med; 2020 Oct; 46(4):1274-1288. PubMed ID: 32945427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
